ARCHIVES

CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years

This article is from The Cancer Letter archive.

Vol. 25 No. 15 | April 16, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

Public Health Service: NIEHS, CDC to Study Population Exposure to Environmental Estrogens

December 12, 1997

DCT Board Okays Recompetitions

June 21, 1985

Excerpts Presented From Pepper Hearing

July 20, 1979

House-Senate Conference Agrees On $1 Billion For NCI, Increases For All NIH Organizations

August 3, 1979

Guest Editorial: Cancer from Fukushima? Is Sushi-Eating Over?

March 16, 2012